Overview
Asa Nixon is a Radiation Oncologist in Peabody, Massachusetts. Dr. Nixon is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Nixon is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Essex Ctr Dr, Peabody, MA 01960
1 Elliot Way, Department Of Radiation Oncology, Manchester, NH 03103
1 Hospital Dr, Lowell, MA 01852
41 Mall Rd, Burlington, MA 01805
Brigham And Women's Hospital, Department Of Radiation Oncology
Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy. He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Brigham And Women's Hospital, Department Of Radiation Oncology
David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Massachusetts General Physicians Organization Inc
Florence Keane is a Radiation Oncologist in Boston, Massachusetts. Dr. Keane is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Pancreaticoduodenectomy. Dr. Keane is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Nixon isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Nixon isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Nixon isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Nixon isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Nixon isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Nixon isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Nixon isAdvanced. Learn about Adenoid Cystic Carcinoma.
- AngiosarcomaDr. Nixon isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Nixon isAdvanced. Learn about Breast Cancer.
- Familial Pancreatic CancerDr. Nixon isAdvanced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Nixon isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Acoustic NeuromaDr. Nixon isExperienced. Learn about Acoustic Neuroma.
- Adult Soft Tissue SarcomaDr. Nixon isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Nixon isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Nixon isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Nixon isExperienced. Learn about Anal Cancer.
- AstrocytomaDr. Nixon isExperienced. Learn about Astrocytoma.

